Taken together, these pieces of evidence demonstrated that RUNX2 transcriptionally sustains metabolic rewiring by simultaneously repressing mitochondrial oxidative respiration and promoting de novo lipogenesis in both TC and BC cancer models, highlighting this biological function as a central part of the pro-oncogenic program orchestrated by this TF. The gene discussed is RUNX2; the disease is cancer.